General Information of the Compound
Compound ID
CP0905192
Compound Name
4-(1H-benzo[d]imidazol-1-yl)-1-(2-(piperidin-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidine
    Show/Hide
Structure
Formula
C19H21N7
Molecular Weight
347.426
Canonical SMILES
c1ccc2c(c1)ncn2-c1ncnc2c1cnn2CCN1CCCCC1
    Show/Hide
InChI
InChI=1S/C19H21N7/c1-4-8-24(9-5-1)10-11-26-19-15(12-23-26)18(20-13-21-19)25-14-22-16-6-2-3-7-17(16)25/h2-3,6-7,12-14H,1,4-5,8-11H2
    Show/Hide
InChIKey
GWKFIZCQPOMDKL-UHFFFAOYSA-N
Physicochemical Property
logP
2.6511
Rotatable Bonds
4
Heavy Atom Count
26
Polar Areas
64.66
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
7
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 71226102
ChEMBL ID
CHEMBL4287021
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01509, Sigma non-opioid intracellular receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 112 nM
   TI
   LI
   LO
   TS